Abstract Background Aortic stenosis is a life-limiting condition for which transcatheter aortic valve implantation (TAVI) is an established therapy. Coronary
Transcatheter heart valves technologies
Abstract Background Aortic stenosis is a life-limiting condition for which transcatheter aortic valve implantation (TAVI) is an established therapy. Coronary
Transcatheter heart valves technologies
Abstract Objective The purpose of this study is to evaluate the efficacy of deep learning reconstruction (DLR) on low-tube-voltage computed
Transcatheter heart valves technologies
Abstract Background Atrial fibrillation (AF) is common in patients undergoing transcatheter aortic valve replacement (TAVR) and is associated with increased
Transcatheter heart valves technologies
Abstract Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active
Transcatheter heart valves technologies
Abstract Aims To evaluate the impact of neutrophil-to-lymphocyte ratio (NLR) on periprocedural pulmonary hypertension (PH) and 3-month all-cause mortality in
Transcatheter heart valves technologies
Abstract Background Transcatheter Aortic Valve Implantation (TAVI) has a growing target population after being indicated even in low-surgical-risk patients with
Transcatheter heart valves technologies
Abstract Transcatheter aortic valve replacement (TAVR) is a well‐established procedure using a catheter‐introduced valve prosthesis for patients with severe aortic
Transcatheter heart valves technologies
Abstract Background The risk and timing of permanent pacemaker implantation (PPMI) after transcatheter aortic valve replacement (TAVR) is still hard
Transcatheter heart valves technologies
Abstract This manuscript describes the feasibility and approach to the assessment and performance of transcatheter pulmonary valve replacement (tPVR) in